drugset / Trial / NCT06975891
Performance of Systane PRO Versus Refresh Optive Mega-3
RandomizedCrossoverQuadruple-blindBasic science
Summary
Single site, prospective, double-masked, randomized-controlled, cross-over study of the subjective and objective performance of 2 different eyedrops. Subjects will be assessed at a screening visit, and 3 follow-up visits. Clinical evaluations will include patient questionnaires.
Timeline
- Start
- 2025-05-15
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Refresh Optive MEGA-3 | Other / unclassified | — | — |
| Subject | Systane PRO | Unknown | — | — |